Maravai Lifesciences Holdings, Inc. (MRVI)
7.845
-0.68
(-7.92%)
USD |
NASDAQ |
Oct 06, 16:00
7.845
0.00 (0.00%)
After-Hours: 19:00
Maravai Lifesciences Holdings Cash from Investing (Quarterly) : -0.37M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.37M |
| March 31, 2026 | -4.437M |
| December 31, 2025 | -2.114M |
| September 30, 2025 | -2.926M |
| June 30, 2025 | -3.236M |
| March 31, 2025 | -23.13M |
| December 31, 2024 | -4.931M |
| September 30, 2024 | -8.959M |
| June 30, 2024 | -6.182M |
| March 31, 2024 | -4.244M |
| December 31, 2023 | -12.90M |
| September 30, 2023 | -15.52M |
| June 30, 2023 | -24.16M |
| Date | Value |
|---|---|
| March 31, 2023 | -69.73M |
| December 31, 2022 | -18.52M |
| September 30, 2022 | -5.847M |
| June 30, 2022 | -1.661M |
| March 31, 2022 | -241.58M |
| December 31, 2021 | -5.656M |
| September 30, 2021 | 118.63M |
| June 30, 2021 | -4.533M |
| March 31, 2021 | -2.784M |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | -3.059M |
| March 31, 2020 | 28.07M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Repligen Corp. | -2.089M |
| Bio-Techne Corp. | -7.057M |
| BioLife Solutions, Inc. | -1.579M |
| MindWalk Holdings Corp. | -0.0559M |
| MaxCyte, Inc. | 6.566M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.992M |
| Cash from Financing (Quarterly) | -98.98M |
| Free Cash Flow | -35.11M |
| Free Cash Flow Per Share (Quarterly) | 0.0245 |
| Free Cash Flow to Equity (Quarterly) | 97.81M |
| Free Cash Flow to Firm (Quarterly) | 8.393M |
| Free Cash Flow Yield | -3.06% |